Publications by authors named "Teja Devarakonda"

Claim this Profile
S
SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy.
Anna Kovilakath, Adolfo G Mauro, Yolander A Valentine, Frank J Raucci, Maryam Jamil, Teja Devarakonda

Circulation· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic pneumonia.
Neha Sharma, Ratul Seal, Devarakonda Uday Teja, Ashok Kumar Pannu

BMJ Case Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic treatment with serelaxin mitigates adverse remodeling in a murine model of ischemic heart failure and modulates bioactive sphingolipid signaling.
Teja Devarakonda, Juan Valle Raleigh, Adolfo G Mauro, Johana M Lambert, Lauren Ashley Cowart

Sci Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrashort Duration Prophylaxis for Hepatitis C Donor Positive to Recipient Negative Simultaneous Kidney/Pancreas Transplants.
Gaurav Gupta, Teja Devarakonda, Aadi Sharma, Madeleine Miles, Idris Yakubu

Transplantation· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of Mechanisms and Treatment of Cancer-Induced Cardiac Cachexia.
Vignesh Vudatha, Teja Devarakonda, Christopher Liu, Devon C Freudenberger, Andrea N Riner

Cells· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Gene Therapy With Relaxin Receptor 1 Overexpression Protects Against Acute Myocardial Infarction.
Teja Devarakonda, Adolfo G Mauro, Chad Cain, Anindita Das, Fadi N Salloum

JACC Basic Transl Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
Teja Devarakonda, Adolfo G Mauro, Geronimo Guzman, Sahak Hovsepian, Chad Cain

J Am Heart Assoc· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional analysis of molecular and pharmacological modulators of mitochondrial fatty acid oxidation.
Yibao Ma, Wei Wang, Teja Devarakonda, Huiping Zhou, Xiang-Yang Wang

Sci Rep· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote Ischemic Pre-Conditioning Attenuates Adverse Cardiac Remodeling and Mortality Following Doxorubicin Administration in Mice.
Zachary M Gertz, Chad Cain, Donatas Kraskauskas, Teja Devarakonda, Adolfo G Mauro

JACC CardioOncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacubitril/Valsartan Averts Adverse Post-Infarction Ventricular Remodeling and Preserves Systolic Function in Rabbits.
Juan Torrado, Chad Cain, Adolfo G Mauro, Francisco Romeo, Ramzi Ockaili, Teja Devarakonda

J Am Coll Cardiol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart Disease and Relaxin: New Actions for an Old Hormone.
Teja Devarakonda, Fadi N Salloum

Trends Endocrinol Metab· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
Juan Valle Raleigh, Adolfo G Mauro, Teja Devarakonda, Carlo Marchetti, Jun He

Cardiovasc Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis